DENNIS PHILLIP ANDREW (Chief Medical Officer) sold 5.1% of their position (8.49K shares) of NOVABRIDGE BIOSCIENCES on the open market
Open‑market sale worth $5.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/22/2026ACC: 0002089237-26-000006
Officer· Chief Medical Officer
Since Mar 2026
+4.90K
Net shares
Net buyer
$5.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
23.70K acquired · 18.80K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+23.70K
Price / share
—
Trade value
—
% of position
16.6%
6/17/2026
142.74K→166.44K
Ordinary Shares
Direct
Shares
−8.49K
Price / share
$0.66
Trade value
$5.61K
% of position
5.1%
6/18/2026
166.44K→157.94K
Total
Net shares
+15.20K
Net value
-$5.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 6/17/2026 | M · Option Exercise | +23.70K | — | — | 16.6% | 142.74K | 166.44K |
| Ordinary Shares Direct | 6/18/2026 | S · Sale | −8.49K | $0.66 | $5.61K | 5.1% | 166.44K | 157.94K |
| Total | +15.20K | -$5.61K | ||||||
Derivative Transactions1
Restricted Share Units
Direct
Converts to
Ordinary Shares
10.30K shares
Shares
−10.30K
Strike price
Held after
82.42K
Exercisable
—
6/17/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Share Units Direct | Ordinary Shares10.30K shares | 6/17/2026 | M · Option Exercise | −10.30K | — | 82.42K |